PPH

VanEck Pharmaceutical ETF

Investor Moves

NameValueActionChangePriceCurrent Price
Jefferies GroupInvestor
$2.9M28k shares
AddQ1 2026
$2.6M
$103.88
$104.81
Jim SimonsRenaissance Technologies
$-959.5K
ExitQ1 2026
$959k
--
$104.81
Ken GriffinCitadel Advisors
$-907.9K
ExitQ1 2026
$908k
--
$104.81
Ken FisherFisher Asset Management
$1.6M15.1k shares
TrimQ1 2026
$22k
$103.88
$104.81
Ken GriffinCitadel Advisors
$908k8.8k shares
ExitQ4 2025
$5.8M
$103.17
$104.81
Ken GriffinCitadel Advisors
$908k8.8k shares
TrimQ4 2025
$4.9M
$103.17
$104.81

News

fool.comVanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy?fool.comJun 18etftrends.comHealthcare ETFs: From Broad Exposure to Big Breakthroughsetftrends.comJun 11zacks.comInside the GLP-1 Boom: ETF Picks for the Obesity Drug Marketzacks.comJun 10zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?zacks.comJun 5fool.comAdding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns.fool.comJun 2
PPH smart money exposure | 交易笔记